GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Float Percentage Of Total Shares Outstanding

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Float Percentage Of Total Shares Outstanding : 18.84% (As of Apr. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Regencell Bioscience Holdings's float shares is 2.45 Mil. Regencell Bioscience Holdings's total shares outstanding is 13.01 Mil. Regencell Bioscience Holdings's float percentage of total shares outstanding is 18.84%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Regencell Bioscience Holdings's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Regencell Bioscience Holdings's Institutional Ownership is 0.05%.


Regencell Bioscience Holdings Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Regencell Bioscience Holdings's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=2.45/13.01
=18.84%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry
Traded in Other Exchanges
N/A
Address
29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Headlines

From GuruFocus